Meadow Creek Investment Management LLC bought a new position in shares of Tabula Rasa HealthCare Inc (NASDAQ:TRHC) in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund bought 1,802 shares of the company’s stock, valued at approximately $115,000.

Several other hedge funds also recently added to or reduced their stakes in the company. Stratos Wealth Partners LTD. acquired a new position in Tabula Rasa HealthCare during the first quarter worth about $122,000. Mason Street Advisors LLC acquired a new position in Tabula Rasa HealthCare during the first quarter worth about $139,000. Mckinley Capital Management LLC Delaware boosted its position in Tabula Rasa HealthCare by 60.5% during the second quarter. Mckinley Capital Management LLC Delaware now owns 2,431 shares of the company’s stock worth $155,000 after acquiring an additional 916 shares during the last quarter. Pinebridge Investments L.P. acquired a new position in Tabula Rasa HealthCare during the second quarter worth about $181,000. Finally, New York State Teachers Retirement System acquired a new position in Tabula Rasa HealthCare during the first quarter worth about $182,000. 75.15% of the stock is owned by institutional investors and hedge funds.

NASDAQ:TRHC opened at $89.37 on Wednesday. The company has a current ratio of 0.36, a quick ratio of 0.33 and a debt-to-equity ratio of 0.11. The stock has a market capitalization of $1.70 billion, a price-to-earnings ratio of -2,234.25, a PEG ratio of 6.52 and a beta of 2.64. Tabula Rasa HealthCare Inc has a 1-year low of $21.50 and a 1-year high of $91.16.

Tabula Rasa HealthCare (NASDAQ:TRHC) last posted its earnings results on Tuesday, August 7th. The company reported $0.20 earnings per share for the quarter, beating the consensus estimate of $0.08 by $0.12. The company had revenue of $48.60 million for the quarter, compared to analyst estimates of $46.73 million. Tabula Rasa HealthCare had a negative net margin of 16.78% and a positive return on equity of 4.55%. equities analysts expect that Tabula Rasa HealthCare Inc will post 0.52 EPS for the current fiscal year.

A number of equities analysts recently weighed in on TRHC shares. Zacks Investment Research upgraded shares of Tabula Rasa HealthCare from a “sell” rating to a “buy” rating and set a $53.00 price target on the stock in a research report on Tuesday, May 15th. Chardan Capital boosted their price target on shares of Tabula Rasa HealthCare from $50.00 to $68.00 and gave the stock a “buy” rating in a research report on Friday, May 18th. MED boosted their price target on shares of Tabula Rasa HealthCare from $47.00 to $63.00 and gave the stock an “outperform” rating in a research report on Monday, May 21st. Robert W. Baird boosted their price target on shares of Tabula Rasa HealthCare from $50.00 to $65.00 and gave the stock an “outperform” rating in a research report on Monday, June 18th. Finally, Piper Jaffray Companies boosted their price target on shares of Tabula Rasa HealthCare to $71.00 and gave the stock an “overweight” rating in a research report on Wednesday, August 8th. Three research analysts have rated the stock with a hold rating, eleven have issued a buy rating and one has assigned a strong buy rating to the stock. The stock currently has a consensus rating of “Buy” and an average price target of $68.08.

In other Tabula Rasa HealthCare news, CEO Calvin H. Knowlton sold 8,000 shares of the business’s stock in a transaction dated Friday, September 7th. The shares were sold at an average price of $85.98, for a total value of $687,840.00. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Insiders sold a total of 48,000 shares of company stock worth $3,317,760 over the last quarter. 14.00% of the stock is currently owned by company insiders.

Tabula Rasa HealthCare Profile

Tabula Rasa HealthCare, Inc operates as a healthcare technology company in the United States. It offers medication risk management, pharmacy cost management, and medicare risk adjustment services. The company offers its technology-enabled products and services to prescribers, pharmacists, and healthcare organizations for medication risk management and risk adjustment.

Recommended Story: Short Selling Stocks, A Beginner’s Guide

Want to see what other hedge funds are holding TRHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Tabula Rasa HealthCare Inc (NASDAQ:TRHC).

Institutional Ownership by Quarter for Tabula Rasa HealthCare (NASDAQ:TRHC)

Receive News & Ratings for Tabula Rasa HealthCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tabula Rasa HealthCare and related companies with MarketBeat.com's FREE daily email newsletter.